FDA declines to issue specific guidance on health programs' foreign drug imports
- Postato il 6 aprile 2026
- Di CNBC
- 0 Visualizzazioni
FDA declines to issue specific guidance on health programs' foreign drug imports
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regulators say is a violation of import laws.
